Vergo Pharma Research Laboratories Profile
Key Indicators
- Authorised Capital ₹ 27.00 Cr
as on 27-06-2024
- Paid Up Capital ₹ 27.00 Cr
as on 27-06-2024
- Company Age 14 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 28.00 Cr
as on 27-06-2024
- Satisfied Charges ₹ 14.50 Cr
as on 27-06-2024
- Revenue 24.95%
(FY 2023)
- Profit -383.51%
(FY 2023)
- Ebitda -1392.09%
(FY 2023)
- Net Worth -32.51%
(FY 2023)
- Total Assets -2.07%
(FY 2023)
About Vergo Pharma Research Laboratories
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 27.00 Cr and a paid-up capital of Rs 27.00 Cr.
The company currently has active open charges totaling ₹28.00 Cr. The company has closed loans amounting to ₹14.50 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Vergo Pharma Research Laboratories Private Limited India are Pouras Rane as COMPANY SECRETARY and Rajiv Mundhra as Cfo. Praveen Khullar, Gajanan Surlakar, Vini Keni, and Two other members serve as directors at the Company.
- CIN/LLPIN
U73200GA2010PTC006462
- Company No.
006462
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Aug 2010
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Goa
Industry
Company Details
- Location
North Goa, Goa, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Vergo Pharma Research Laboratories?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pouras Rane  | Company Secretary | 12-Jun-2019 | Current |
| Prasad Keni | Managing Director | 10-Aug-2010 | Current |
| Rajiv Mundhra | CFO | 29-Jun-2023 | Current |
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kashyap Keni | Director | 19-Sep-2019 | Current |
| Praveen Khullar | Director | 06-Apr-2022 | Current |
| Gajanan Surlakar | Director | 29-Apr-2020 | Current |
| Vini Keni | Director | 10-Aug-2010 | Current |
Financial Performance and Corporate Structure Insights of Vergo Pharma Research Laboratories.
Vergo Pharma Research Laboratories Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 24.95% increase. The company also saw a substantial fall in profitability, with a 383.51% decrease in profit. The company's net worth observed a substantial decline by a decrease of 32.51%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vergo Pharma Research Laboratories?
In 2023, Vergo Pharma Research Laboratories had a promoter holding of 100.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Vergo Pharma Research Private LimitedActive 14 years 2 monthsPraveen Khullar, Vini Keni and 2 more are mutual person
Vilman Healthcare Private LimitedActive 39 years 5 monthsGajanan Surlakar, Vini Keni and 2 more are mutual person
- V.G. Quenim Mining Private Limited.Active 31 years 7 months
Vini Keni, Prasad Keni and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 20 Oct 2021 | ₹10.00 Cr | Open |
Others Creation Date: 20 Oct 2021 | ₹18.00 Cr | Open |
Axis Bank Limited Creation Date: 18 Aug 2020 | ₹14.50 Cr | Satisfied |
How Many Employees Work at Vergo Pharma Research Laboratories?
Vergo Pharma Research Laboratories has a workforce of 182 employees as of Apr 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vergo Pharma Research Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vergo Pharma Research Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
